Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 571 AL 585

Microbial amyloids--functions and interactions within the host

Schwartz K, Boles BR.

Curr Opin Microbiol. 2013 Feb;16(1):93-9. doi: 10.1016/j.mib.2012.12.001. Epub 2013 Jan 9.

Haptic feedback from manual contact improves balance control in people with Parkinson's disease

Rabin E, Chen J, Muratori L, DiFrancisco-Donoghue J, Werner WG.

Gait Posture. 2013 Jul;38(3):373-9. doi: 10.1016/j.gaitpost.2012.12.008. Epub 2013 Jan 11.

Basal ganglia lesions in children and adults

Bekiesinska-Figatowska M, Mierzewska H, Jurkiewicz E.

Eur J Radiol. 2013 May;82(5):837-49. doi: 10.1016/j.ejrad.2012.12.006. Epub 2013 Jan 10.

DemTect, PANDA, EASY, and MUSIC: cognitive screening tools with age correction and weighting of subtests according to their sensitivity and specificity

Kalbe E, Calabrese P, Fengler S, Kessler J.

J Alzheimers Dis. 2013;34(4):813-34. doi: 10.3233/JAD-122128.

Parkinsonism can be cured

Lobo R, Fraser A, Kiely P, Boers P.

BMJ Case Rep. 2013 Jan 10;2013:bcr2012008057. doi: 10.1136/bcr-2012-008057.

The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models

Sato H, Kato T, Arawaka S.

Rev Neurosci. 2013;24(2):115-23. doi: 10.1515/revneuro-2012-0071.

Use of antidepressants for depression in patients with Parkinson's disease

Pae CU.

Expert Opin Pharmacother. 2013 Feb;14(3):255-7. doi: 10.1517/14656566.2013.759213. Epub 2013 Jan 14.

The awakening of artistic creativity and Parkinson's disease

Inzelberg R.

Behav Neurosci. 2013 Apr;127(2):256-61. doi: 10.1037/a0031052. Epub 2013 Jan 14.

Neuroactive insecticides: targets, selectivity, resistance, and secondary effects

Casida JE, Durkin KA.

Annu Rev Entomol. 2013;58:99-117. doi: 10.1146/annurev-ento-120811-153645.

A review of methods used to study cognitive deficits in Parkinson's disease

Rana AQ, Masroor MS, Khan AS.

Neurol Res. 2013 Jan;35(1):1-6. doi: 10.1179/1743132812Y.0000000118.

Parkinson's disease in the nuclear age of neuroinflammation

Nolan YM, Sullivan AM, Toulouse A.

Trends Mol Med. 2013 Mar;19(3):187-96. doi: 10.1016/j.molmed.2012.12.003. Epub 2013 Jan 11.

Subthalamic nucleus: a key structure for emotional component synchronization in humans

Péron J, Frühholz S, Vérin M, Grandjean D.

Neurosci Biobehav Rev. 2013 Mar;37(3):358-73. doi: 10.1016/j.neubiorev.2013.01.001. Epub 2013 Jan 12.

Differences in brain activation between tremor- and nontremor-dominant Parkinson disease

Prodoehl J, Planetta PJ, Kurani AS, Comella CL, Corcos DM, Vaillancourt DE.

JAMA Neurol. 2013 Jan;70(1):100-6. doi: 10.1001/jamaneurol.2013.582.

Effects of resistance training for people with Parkinson's disease: a systematic review

Brienesse LA, Emerson MN.

J Am Med Dir Assoc. 2013 Apr;14(4):236-41. doi: 10.1016/j.jamda.2012.11.012. Epub 2013 Jan 11.

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease

Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM.

Pharmacol Rev. 2013 Jan 10;65(1):171-222. doi: 10.1124/pr.111.005678. Print 2013 Jan.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias